Patents Assigned to The University of Washington
-
Publication number: 20250145926Abstract: Various implementations described herein relate to devices, systems, and methods for inducing and/or causing cellular migration and uses thereof. Implementations described herein can be used to cause a portion of a cell population to migrate in response to a differential stimulus. Implementations described herein can be used to isolate and characterize the portion of the cell population. Implementations described herein can be used for research, diagnostic, or therapeutic purposes.Type: ApplicationFiled: October 31, 2024Publication date: May 8, 2025Applicant: University of WashingtonInventors: Nathan Belliveau, Julie Theriot, Matthew Footer
-
Publication number: 20250145957Abstract: Provided herein are compositions and methods directed toward the discovery of improved methods for generating deoxyATP (dATP) in cells that can be delivered to a graft site in the heart to enhance cardiac function.Type: ApplicationFiled: August 16, 2024Publication date: May 8, 2025Applicant: UNIVERSITY OF WASHINGTONInventors: Michael REGNIER, Charles E. MURRY, Stephen D. HAUSCHKA
-
Patent number: 12294228Abstract: Examples of charging systems are described which may utilize a network of resonator circuits. Control methods are described which may locate a charging location at which an electronic device is placed proximate the charging system and identify a path of resonator circuits to activate to charge the electronic device. Individual resonator circuits in the path may be activated by selecting a resonant frequency of the resonator circuit such that power may be transferred by the resonator circuit at an operating frequency.Type: GrantFiled: February 25, 2021Date of Patent: May 6, 2025Assignee: University of WashingtonInventors: Joshua R. Smith, Xingyi Shi
-
Patent number: 12291652Abstract: Zwitterionic double network hydrogels, methods for making zwitterionic double network hydrogels, methods for using zwitterionic double network hydrogels, and articles made from and coated with zwitterionic double network hydrogels.Type: GrantFiled: August 14, 2019Date of Patent: May 6, 2025Assignee: University of WashingtonInventors: Shaoyi Jiang, Hsiang-Chieh Hung, Dianyu Dong, Caroline Tsao, Chenjue Tang, Joel MacArthur
-
Publication number: 20250138021Abstract: This application relates to oligomer barcodes for labeling extracellular vesicles (EVs). The labeled extracellular vesicles can be used to monitor EV movement for research purposes and for the development of treatments in a variety of diseases and disorders.Type: ApplicationFiled: October 29, 2024Publication date: May 1, 2025Applicant: University of WashingtonInventors: Elizabeth Nance, Nam Phuong H Nguyen, Shahrokh Paktinat, Lucia Vojtech, Mengying Zhang
-
Publication number: 20250135016Abstract: The present disclosure features, inter alia, a cyclic multifunctional linker, including at least two cleavable moieties; at least two connecting chains connected to the at least two cleavable moieties to provide a cyclic structure; and at least two linking groups, each linking group being bonded at one end to a connecting chain and being located between two cleavable moieties, and each linking group having a second end configured to bond to crosslinkable moieties. In the cyclic multifunctional linker, each connecting chain has at least two ends, and at least two of the connecting chains are each connected at each end to a cleavable moiety.Type: ApplicationFiled: November 1, 2024Publication date: May 1, 2025Applicant: University of WashingtonInventors: Cole DeForest, Barry Badeau
-
Publication number: 20250136112Abstract: In some embodiments, a method of controlling speed of an ego vehicle in a vehicle platoon is provided. Cooperative adaptive cruise control (CACC) commands based on at least one of a vehicle-to-vehicle communication control received from a preceding vehicle and a feedback control based on a sensor output of a long-range sensor of the ego vehicle are provided to a speed controller. In response to detecting an occluded state, a minimum spacing value and a minimum relative velocity value between the ego vehicle and the preceding vehicle are determined based on information received before the detection of the occluded state; a safety speed based on the minimum spacing value and the minimum relative velocity value is determined; and an occluded adaptive cruise control command is provided to the speed controller to maintain a speed of the ego vehicle that is less than or equal to the safety speed.Type: ApplicationFiled: September 9, 2022Publication date: May 1, 2025Applicants: University of Washington, University of PortlandInventors: Yudong Lin, Santosh Devasia, Brian Fabien
-
Patent number: 12285482Abstract: Compositions including a CD180 binding ligand and a linked Hepatitis B antigen and their use are disclosed. The Hepatitis B antigen includes Hepatitis B virus pre-S1 and/or pre-S2 region of the HBV envelope protein (HBVpreS1/S2Ag), L-HBsAg, MHBsAg, S-HBsAg, or antigenic fragments or mutants thereof.Type: GrantFiled: July 1, 2022Date of Patent: April 29, 2025Assignees: UNIVERSITY OF WASHINGTON, ABACUS BIOSCIENCE, INC.Inventors: Edward A. Clark, Che-Leung Law, Deborah Fuller, Michael Gale
-
Patent number: 12285636Abstract: Non-planar holographic beam shaping lenses for acoustics are disclosed herein. In one embodiment, an ultrasonic therapy system that is configured to apply ultrasound to a target in a body includes: an ultrasonic transducer configured to generate the ultrasound; and a customizable holographic lens configured to focus the ultrasound onto a focal area of a target that is an object or a portion of the object in the body. The customizable holographic lens is designed and produced based on the target. Furthermore, the customizable holographic lens is curved to mate with a front surface of the ultrasonic transducer.Type: GrantFiled: August 4, 2022Date of Patent: April 29, 2025Assignee: The University of WashingtonInventors: Michael R. Bailey, Mohamed Abdalla Ghanem, Adam D. Maxwell
-
Publication number: 20250130230Abstract: Provided herein are methods of detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in a sample. The methods include contacting the sample with a plurality of gold nanoparticles (AuNPs) and/or other plasmonic metal nanoparticles (MNPs) that are conjugated with at least two sets of antibodies, or antigen binding portions thereof, that binds to at least first and second epitopes of SARS-CoV-2 proteins, such as receptor-binding domain (RBDs) under conditions sufficient for the antibodies, or the antigen binding portions thereof, to bind to the first and second epitopes of the SARS-CoV-2 proteins in the sample to produce bound SARS-CoV-2 proteins. The methods also include detecting the SARS-CoV-2 proteins when aggregations of the bound SARS-CoV-2 proteins form with one another. Related compositions, reaction mixtures, devices, kits, and systems are also provided.Type: ApplicationFiled: September 27, 2022Publication date: April 24, 2025Applicants: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, UNIVERSITY OF WASHINGTONInventors: Chao Wang, Liangcai Gu, Xiahui Chen, Shoukai Kang, MD Ashif Ikbal, Zhi Zhao
-
Publication number: 20250130444Abstract: Spatial light modulators and associated methods are described. In one embodiment, a spatial light modulator includes a photonic integrated circuit configured for emitting a plurality of light beams as a first waveform by a plurality of pixels. The light beams are individually controllable. The spatial light modulator also includes a meta-optic having a plurality of nanostructures configured for receiving the first waveform and aggregating the plurality of light beams as a second waveform at a surface of the meta-optic. The spatial light modulator also includes an aperture array configured for converting the second waveform into a third waveform, where the third waveform is smaller than the second waveform.Type: ApplicationFiled: July 30, 2024Publication date: April 24, 2025Applicant: UNIVERSITY OF WASHINGTONInventors: Virat Tara, Anna-Wirth Singh, Abhi Saxena, Johannes Emanuel Fröch, Matthew S. Reynolds, Rui Chen, Arka Majumdar
-
Publication number: 20250129132Abstract: Described herein is a generalizable strategy to rapidly and irreversibly activate protein function with full spatiotemporal control. Through development of an exogenously triggerable self-assembling protein construct, bioactive proteins can be stably reassembled from non-functional split fragment pairs following exposure to a stimulus (e.g., light).Type: ApplicationFiled: September 21, 2022Publication date: April 24, 2025Applicant: University of WashingtonInventors: Cole Alexander DeForest, Emily R. Ruskowitz
-
Patent number: 12280376Abstract: Devices and systems for droplet generation and methods for generating droplets are described. In an embodiment, the devices and systems include a capillary configured to eject a droplet, such as in response to a voltage applied to an end of the capillary. In an embodiment, the devices and systems include a moveable stage configured to carry a multi-well plate and move the stage relative to the capillary such that the ejected droplet is selectively received by a well of the multi-well plate carried by the moveable stage.Type: GrantFiled: February 4, 2020Date of Patent: April 22, 2025Assignee: University of WashingtonInventors: Daniel Chiu, Li Wu, Yuling Qin
-
Publication number: 20250122318Abstract: Crosslinked films having electro-optic activity, compositions and compounds for making the films, methods for making the films, and devices that include the films are disclosed.Type: ApplicationFiled: December 20, 2024Publication date: April 17, 2025Applicant: University of WashingtonInventors: Delwin Elder, Huajun Xu, Bruce H. Robinson, Larry R. Dalton
-
Publication number: 20250121038Abstract: Provided herein are isolated nucleic acids that encode a stable form of Rrm2 for the use of increasing the intracellular Rrm2 protein levels and cytosolic 2-deoxy-ATP (dATP) levels. Further provided herein are methods for treating a cardiac disease or disorder, e.g., myocardial infarction or myocardial ischemia, by administering the isolated nucleic acids, a polypeptide encoded by the isolated nucleic acids, or composition comprising the isolated nucleic acids to a subject in need thereof.Type: ApplicationFiled: December 16, 2024Publication date: April 17, 2025Applicant: UNIVERSITY OF WASHINGTONInventors: Michael REGNIER, Charles E. MURRY, Xuan GUAN
-
Patent number: 12275757Abstract: Disclosed herein are nanostructures and their use, where the nanostructures include (a) a plurality of first assemblies, each first assembly comprising a plurality of identical first polypeptides; (b) a plurality of second assemblies, each second assembly comprising a plurality of identical second polypeptides, wherein the second polypeptide differs from the first polypeptide; wherein the plurality of first assemblies non-covalently interact with the plurality of second assemblies to form a nanostructure; and wherein the nanostructure displays multiple copies of one or more paramyxovirus and/or pneumovirus F proteins or antigenic fragments thereof, on an exterior of the nanostructure.Type: GrantFiled: June 20, 2023Date of Patent: April 15, 2025Assignees: UNIVERSITY OF WASHINGTON, INSTITUTE FOR RESEARCH IN BIOMEDICINEInventors: Neil P. King, David Baker, Brooke Fiala, Lance Joseph Stewart, Laurent Perez, Antonio Lanzavecchia, Jessica Marcandalli, Jorge Fallas, Yang Hsia
-
Publication number: 20250118545Abstract: A system may control a mass spectrometer to acquire, during a plurality of acquisitions constituting an acquisition cycle, a set of mass spectra of product ions derived from precursor ions isolated based on a parallel isolation window successively positioned throughout a precursor mass-to-charge ratio (m/z) range. The precursor m/z range is divided into a plurality of isolation window units. The parallel isolation window includes, for each acquisition of the acquisition cycle, a set of isolation sub-windows corresponding to a distinct set of isolation window units of the precursor m/z range. At least two adjacent isolation sub-windows of the parallel isolation window are non-contiguous. Each isolation window unit of the precursor m/z range is analyzed at least twice during the acquisition cycle. A mass spectrum for the precursor m/z range may be generated based on the set of mass spectra acquired during the acquisition cycle.Type: ApplicationFiled: October 6, 2023Publication date: April 10, 2025Applicants: Thermo Finnigan LLC, University of WashingtonInventors: Philip M. Remes, Michael J. MacCoss, Jarrett Egertson
-
Publication number: 20250115528Abstract: Embodiments of the present disclosure provide compositions and methods for increasing nutrient uptake by plants and for effecting soil remediation. Embodiments of the composition and methods comprise a hydrogel bead, a microbial consortia, and a fungi, and can additionally comprise an excipient for administration of the hydrogel bead comprising the microbial consortia and the fungi, one or more seed, water, one or more nutrients, and combinations thereof. Such composition and methods have broad application to reduce fertilizer requirements and use, and to increase plant nutrient access and uptake. The composition and methods have additional application to remediate contaminated mediums such as soil contaminated with chemicals, petroleum, and explosives.Type: ApplicationFiled: January 5, 2023Publication date: April 10, 2025Applicant: University of WashingtonInventors: Mari-Karoliina Henriikka Winkler, Korena Mafune
-
Patent number: 12269764Abstract: Hydrogels for entrapment of live microorganisms and methods of their use, such as in wastewater purification, are disclosed.Type: GrantFiled: October 13, 2020Date of Patent: April 8, 2025Assignee: University of WashingtonInventors: Raymond Redcorn, Mari-Karoliina Henriikka Winkler, Bruce Godfrey, David A. Stahl
-
Patent number: 12270067Abstract: The present disclosure provides nanoparticle transducers and methods of use thereof for the detection of analyte concentrations in a fluid. Nanoparticle transducers can comprise a nanoparticle, such as a Pdot, coupled to an enzyme that catalyzes a reaction with the analyte. The nanoparticle transducers further comprise chromophores that emit fluorescence that varies as a function of the concentration of one of the elements of the reaction. The nanoparticle transducer thus changes fluorescence as the analyte concentration changes, transforming analyte concentration values into fluorescence intensities. The measurement of these intensities provides a measurement of the analyte concentration. The nanoparticle transducers are biocompatible, allowing for use in vivo, for the monitoring of analyte blood concentrations such as blood glucose concentrations.Type: GrantFiled: November 23, 2022Date of Patent: April 8, 2025Assignees: University of Washington, Lamprogen, Inc.Inventors: Daniel T. Chiu, Jiangbo Yu, Changfeng Wu, Kai Sun